Get startedLog in
    Picture of Ventyx Biosciences logo

    VTYX — Ventyx Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapHigh Flyer
    All News

    Brief: Ventyx Biosciences Announces Positive Topline Results From Phase 2 Study Of Vtx3232 In Participants With Obesity And Cardiovascular Risk Factors

    Picture of Ventyx Biosciences logoVentyx Biosciences
    22/10/2025 22:37
    Oct 22 (Reuters) - Ventyx Biosciences Inc VTYX.O:

VENTYX BIOSCIENCES ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 2 STUDY OF VTX3232 IN PARTICIPANTS WITH OBESITY AND CARDIOVASCULAR RISK FACTORS

VENTYX BIOSCIENCES INC - VTX3232 SAFE AND WELL TOLERATED IN STUDY

Source text: ID:nGNX9x6FbT

Further company coverage: VTYX.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Ventyx Biosciences

    See all news